Search Results

Site Search

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Stories - Insights

Beyond the test result Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’

Dietrich Matern, M.D., Ph.D., Elected to American College of Medical Genetics and Genomics Board - Insights

Dietrich Matern, M.D., Ph.D., Division Chair of Laboratory Genetics in the Department of Laboratory Medicine and Pathology in Rochester, Minnesota, has been appointed as a new director on the board of the American College of Medical...

Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights

In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...

Rare Lyme disease-causing bacteria spotted on routine blood films - Insights

It’s been understood for some time that an infection of B. mayonii, a rare species of bacterium, results in high levels of spirochetes in the peripheral blood. But actually being able to visualize them on a routine peripheral blood smear...

Previous Programs - Insights

Short recordings surrounding disease diagnosis through new methods in testing and treatment.